PRESSRELEASES
15 May, 2025
Bulletin from Nanexa’s Annual General Meeting
The Annual General Meeting (AGM) of Nanexa AB (publ) has been held on May 15, 2025, at which meeting submitted proposals were passed. The complete proposals for resolutions are set out in the AGM notice.
READ MORE6 May, 2025
Nanexa publishes interim report for January-March 2025
Very interesting data from the latest study and successful share issue.
READ MORELATEST REPORTS
PRESENTATIONS
6 May 2025
Q1 report commentary with CEO David Westberg
19 February 2025
Q4 report commentary with CEO David Westberg and Chairman of the board Göran Ando
MEET NANEXA
16 - 19 Jun, 2025
BIO International Convention i Boston, USA
Ett forum för att skapa strategiska partnerskap och licensieringsmöjligheter.
20 - 23 Jun, 2025
American Diabetes Association (ADA) Scientific Sessions i Chicago, USA
Bolagets fas I-data för NEX-22 har accepterats som ett Late Breaking Abstract och kommer att presenteras som poster.
14 - 18 Jul, 2025
Controlled Release Society (CRS) Annual Meeting i Philadelphia, USA
Nanexa håller en entimmes muntlig presentation om PharmaShell®